期刊文献+

PSI评分在重症肺炎患者预后判断中的应用价值 被引量:9

The application value of prognosis about PSI in severe pneumonia cases
下载PDF
导出
摘要 目的探讨重症肺炎患者预后与肺炎严重程度(pneumonia severity index,PSI)评分的关系。方法收集本院32例重症肺炎患者的临床资料,计算PSI分值,观察不同PSI分值患者病死率。结果 PSI≤50分组病死率为0,51~70分组病死率为12.50%,71~90分组病死率为30.00%,91~130分组病死率为50.00%,>130分组病死率为71.43%,5组病死率差异有统计学意义,P<0.01。结论 PSI评分可以用来预测重症肺炎患者的预后。 Objective To investigate the relationship between PSI and the prognosis of severe pneumonia cases.Methods The clinical data of 32 severe pneumonia cases in the respiratory department of our hospital were collected.Computed the score of PSI,the motalities in different PSI scores were compared.Results The motality in PSI score≤50 group was 0.The motality in PSI score 51-70 group was 12.50%.The motality in PSI score 71-90 group was 30.00%.The motality in PSI score 91-130 group was 50.00%.The motality in PSI score 130 group was 71.43%.There were significant differences a mong five groups,P 〈0.01.Conclusion The study shows that PSI is applicable to estimate the prognosis of severe pneu monia cases.
出处 《中国当代医药》 2012年第35期40-41,共2页 China Modern Medicine
关键词 肺炎严重程度 重症肺炎 预后 应用价值 Pneumonia severity index Severe pneumonia cases Prognosis Application value
  • 相关文献

参考文献6

  • 1郭琦,黎毅敏,农凌波,徐远达,何国清,何为群,陈思蓓,刘晓青,李静,江梅,徐永昊,肖正伦,钟南山.重症肺炎及感染性休克的集束治疗[J].中华急诊医学杂志,2009,18(3):286-292. 被引量:44
  • 2邓伟吾.社区获得性肺炎诊断治疗进展[J].中华结核和呼吸杂志,2004,27(1):10-12. 被引量:48
  • 3Querol-Ribelles JM,Tenlas JM ,Querol-Borr6s JM ,et al. Validation of the Pneumonia Severity Index for hospitalizing patients with communi- ty-acquired pneumonia[J], Med Clin (Bare), 2004,122 ( 13 ) ~ 481-486.
  • 4Van der Eerden MM,de Graaff CS,Bronaveld W,et al. Prospective eval- uation of pneumonia severity index in hospitalised patients with commu- nity-acquired pneumonia[J]. Respir Med,2004,98 (9) : 872-878.
  • 5Lim WS,Van der Eerden MM,Laing R,et al. Defining community ac- quired pneumonia severity on presentation to hospital:an international derivation and validation study[J]. Thorax,2003,5 (2) : 377-382.
  • 6但勇,覃双全.PSI评分和CURB-65评分对社区获得性肺炎患者病情及预后的对比研究[J].中国当代医药,2012,19(21):29-30. 被引量:16

二级参考文献45

  • 1刘大为.严重感染和感染性休克的集束治疗策略[J].中华外科杂志,2006,44(17):1178-1180. 被引量:36
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 3邱海波.应强化和落实严重感染的早期加强治疗策略[J].中华急诊医学杂志,2007,16(2):119-120. 被引量:22
  • 4Feikin DR, Schuchat A, Kolczak M, et al. Mortality from invasive pneumococcal pneumonia in tile era of antibiotic resistance, 1995-1997 [J]. Am J Public Health, 2000, 90(2) : 223-229.
  • 5American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventila- tor-associated, and healtheare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005, 171(4): 388-416.
  • 6Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of commtmity-acquired pneumonia in adults [J]. Clin Infect Dis, 2007, 44 (Suppl 2): S27-S72.
  • 7Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000 [J]. N Engl J Med, 2003, 348(16) : 1546-1554.
  • 8Angus DC, Wax RS. Epidemiology of sepsis: an update [J]. Crit Care Med, 2001, 29(Suppl 7): S109-S116.
  • 9Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock [J]. Crit Care Med, 2004, 32(3): 858-873.
  • 10Surviving Sepsis Campaign and Institute for Healthcare Improvement. Sepsis Bundle[EB/OL]. Available at: http://www, ihi. org/IHI/Top ics/CriticalCare/Sepsis/Tools/SevereSepsisBundle, htm (2004).

共引文献105

同被引文献102

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 2百色市政府.百色市政府2013年工作报告[EB/OL].http://www.gxbsrd.gov.on/news-view.php?id=9730.
  • 3覃鸿云,曹震宇.理疗一理当合理治疗[N].家庭医生报,2009-8-31(16).
  • 4Calvano SE,Xiao WZ,Richards DR,et al. A network-based analysis of systemic inflammation in humans [ J ]. Nature, 2005, 437 (7061) :1032 - 1037.
  • 5Brown SM,Dean NC. Defining and predicting severe community-ac- quired pneumonia[ J]. Curt Opin Infect Dis,2010,23 (2) : 158 - 164.
  • 6Mandell LA, Wunderink RG, Anzucto A, et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneu-monia in adults [ J ]. Clin Infect Dis,2007,44 ( Suppl 2) : $27 - 72.
  • 7Marti C, Garin N, Grosgurin 0, et al. Prediction of severe communi- ty-acquired pneumonia: a systematic review and recta-analysis[ J ]. Crit Care ,2012,16 (4) : R141.
  • 8Hohenthal U, Hurme S, Helenius H, et al. Utility of C - reactive pro- tein in assessing the disease severity and complications of communi-ty-acquired pneumonia[ J]. Clin Microbiol Infect,2009,15 ( 11 ) :,1026 - 1032.
  • 9Espana PP, Capelastegui A, Salgado M J, et al. Utility of two biomar- kers for directing care among patients with non-severe community-ac- quired pneumonia [ J ]. Eur J Clin Microbiol Infect Dis, 2012,31 (12) :3397 - 3405.
  • 10Horie M,Ugajin M,Suzuki M,et al. Diagnostic and prognostic value of procalcitonin in community-acIuired pneumonia [ J ]. Am J Med Sei ,2012,343 ( 1 ) :30 - 35.

引证文献9

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部